Abstract：
The benefits of biomedical research involving humans are well recognised, along with the need for conformity to international standards of science and ethics. When human research involves radiation imaging procedures or radiotherapy, an extra level of expert review should be provided from the point of view of radiological protection. The relevant publication of the International Commission for Radiological Protection (ICRP) is now three decades old and is currently undergoing an update. This paper aims to provoke discussions on how the risks of radiation dose and the benefits of research should be assessed, using a case study of diagnostic radiology involving volunteers for whom there is no direct benefit. Further, the paper provides the current understanding of key concepts being considered for review and revision-such as the dose constraint and the novel research methods on the horizon, including radiation biology and epidemiology. The analysis revisits the perspectives described in the ICRP Publication 62, and considers the recent progress in both radiological protection ethics and medical research ethics.
摘要：
涉及人类的生物医学研究的好处是公认的，以及符合国际科学和伦理标准的需要。当人体研究涉及辐射成像程序或放射治疗时，从放射防护的角度来看，应提供额外的专家审查水平。国际辐射防护委员会（ICRP）的相关出版物现在已有三十年的历史，目前正在进行更新。＆＃xD;本文旨在引发关于如何评估辐射剂量风险和研究收益的讨论，使用诊断放射学的案例研究，涉及对没有直接益处的志愿者。Further,本文提供了目前正在考虑审查和修订的关键概念的理解，如剂量限制和新的研究方法在地平线上，包括放射生物学和流行病学。分析重新审视了ICRP出版物62中描述的观点，并考虑了放射保护伦理和医学研究伦理的最新进展。
.
